Real-World data shows how mavacamten helps patients with thick heart muscle
NCT ID NCT07168655
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 24 times
Summary
This study looked at 163 adults with obstructive hypertrophic cardiomyopathy (a condition where the heart muscle is too thick and blocks blood flow) who were treated with the drug mavacamten. Researchers collected information from medical records to see how patients were doing in real life, not in a strict research setting. The goal was to understand the drug's effects on symptoms, heart function, and patient characteristics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.